Cutaneous Squamous Cell Carcinoma Staging Study

Recruiting now

Conditions studied: Cutaneous Squamous Cell Carcinoma

In brief

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer, and one of the most common cancers worldwide. The majority of CSCCs are easily removed by surgery and have excellent prognosis. However, a small subset has poor outcomes, including secondary spread in the body (metastasis) and death. The investigators will look at existing CSCC in people from two UK dermatology centres. The investigators will then evaluate the accuracy of current staging systems in predicting risk of poor outcomes in people. The investigators hope that this project will improve the management of patients with CSCC by validating the predictive power of currently available histological staging classifications for cSCC. In the second stage of the study, The investigators will see whether better prediction tools can be found.

Key facts

Study ID

NCT05695222

Run by

Queen Mary University of London

People needed

1500

Starts

2023-05-01

Expected to finish

2028-06-05

Last updated by the study team

2026-04-02

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Over 18 years old with diagnosis of CSCC

You may not qualify if…

• Patients who decline for their data to be used for research purposes

Where it is running

• Whipps Cross University Hospital — London, United Kingdom (enrolling)
• Dr Emilia Peleva — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.